Non-alcoholic fatty liver disease | Skip to main content

Non-alcoholic fatty liver disease

09-20-2022 | EASD 2022 | Conference coverage | News

Fatty liver index may predict mortality, CVD risk in people with type 1 diabetes

Hepatic steatosis, measured by the fatty liver index, is associated with an increased risk for mortality and cardiovascular disease among people with type 1 diabetes, research suggests.

09-20-2022 | EASD 2022 | Conference coverage | News

Insulin pump delivery may reduce fatty liver risk in type 1 diabetes

Using an insulin pump rather than multiple daily injections may help protect people with type 1 diabetes from developing fatty liver disease, report researchers.

06-22-2022 | SGLT2 inhibitors | News

SGLT1/2 inhibitor shows early promise in NASH

The SGLT1/2 inhibitor licogliflozin has reduced liver enzyme levels in people with nonalcoholic steatohepatitis in a phase 2 trial published in Nature Medicine.

06-05-2022 | ADA 2022 | Conference coverage | News

Almost any liver fat may be abnormal

Researchers report that metabolic abnormalities begin to increase at levels of liver fat commonly regarded as normal.

Overweight person and injection pen

04-27-2022 | Tirzepatide | News

Tirzepatide reduces liver fat, improves time in range

The publication of two SURPASS-3 substudies in The Lancet Diabetes & Endocrinology reveals significant benefits of tirzepatide on liver and abdominal fat in people with type 2 diabetes, as well as on time in target glucose range.

02-04-2022 | Non-alcoholic fatty liver disease | News

Doctors call for NAFLD care pathway in type 2 diabetes

Physicians feel that nonalcoholic fatty liver disease is sidelined in type 2 diabetes management and should be formally incorporated into routine primary care pathways, say Australian researchers.

01-06-2022 | Pathogenesis | News

Genetic study backs role for liver fat, pancreatic volume in type 2 diabetes risk

A genetic propensity for increased liver fat and lower pancreatic volume is associated with an increased risk for type 2 diabetes, say researchers.

11-29-2021 | Metabolic surgery | News

Rival gastric surgery approaches have similar effects on liver fat

Gastric bypass and sleeve gastrectomy both result in “almost complete clearance of liver fat” within a year after the intervention, show secondary outcomes of a randomized trial.